BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 14595383)

  • 1. In vivo adenovirus-mediated delivery of a uPA/uPAR antagonist reduces retinal neovascularization in a mouse model of retinopathy.
    Le Gat L; Gogat K; Bouquet C; Saint-Geniez M; Darland D; Van Den Berghe L; Marchant D; Provost A; Perricaudet M; Menasche M; Abitbol M
    Gene Ther; 2003 Dec; 10(25):2098-103. PubMed ID: 14595383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lentivirus-mediated expression of angiostatin efficiently inhibits neovascularization in a murine proliferative retinopathy model.
    Igarashi T; Miyake K; Kato K; Watanabe A; Ishizaki M; Ohara K; Shimada T
    Gene Ther; 2003 Feb; 10(3):219-26. PubMed ID: 12571629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adenovirus-mediated gene transfer of urokinase plasminogen inhibitor inhibits angiogenesis in experimental arthritis.
    Apparailly F; Bouquet C; Millet V; Noel D; Jacquet C; Opolon P; Perricaudet M; Sany J; Yeh P; Jorgensen C
    Gene Ther; 2002 Feb; 9(3):192-200. PubMed ID: 11859422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adenovirus-mediated delivery of a uPA/uPAR antagonist suppresses angiogenesis-dependent tumor growth and dissemination in mice.
    Li H; Lu H; Griscelli F; Opolon P; Sun LQ; Ragot T; Legrand Y; Belin D; Soria J; Soria C; Perricaudet M; Yeh P
    Gene Ther; 1998 Aug; 5(8):1105-13. PubMed ID: 10326034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A gene transfer comparative study of HSA-conjugated antiangiogenic factors in a transgenic mouse model of metastatic ocular cancer.
    Frau E; Magnon C; Opolon P; Connault E; Opolon D; Beermann F; Abitbol M; Perricaudet M; Bouquet C
    Cancer Gene Ther; 2007 Mar; 14(3):251-61. PubMed ID: 17082795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effects of angiostatin, endostatin and interferon-alpha(1) gene transfer on in vivo growth of human breast cancer cells.
    Indraccolo S; Gola E; Rosato A; Minuzzo S; Habeler W; Tisato V; Roni V; Esposito G; Morini M; Albini A; Noonan DM; Ferrantini M; Amadori A; Chieco-Bianchi L
    Gene Ther; 2002 Jul; 9(13):867-78. PubMed ID: 12080381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of retinal neovascularisation by gene transfer of soluble VEGF receptor sFlt-1.
    Bainbridge JW; Mistry A; De Alwis M; Paleolog E; Baker A; Thrasher AJ; Ali RR
    Gene Ther; 2002 Mar; 9(5):320-6. PubMed ID: 11938451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Transfer of endostatin gene for inhibition of retinal angiogenesis in mice].
    Wang W; Xie LX; Dong XG; Zang XJ
    Zhonghua Yan Ke Za Zhi; 2006 Feb; 42(2):111-5. PubMed ID: 16643724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Downregulation of vascular endothelial growth factor and integrinbeta3 by endostatin in a mouse model of retinal neovascularization.
    Zhang M; Yang Y; Yan M; Zhang J
    Exp Eye Res; 2006 Jan; 82(1):74-80. PubMed ID: 16198337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene therapy for ocular angiogenesis.
    Bainbridge JW; Mistry AR; Thrasher AJ; Ali RR
    Clin Sci (Lond); 2003 Jun; 104(6):561-75. PubMed ID: 12570869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lentivirus-mediated sFlt-1 gene fragment transfer suppresses retinal neovascularization.
    Min Z; Qiang W; Benwen S; Bin L; Xinhua D
    Curr Eye Res; 2009 May; 34(5):401-10. PubMed ID: 19401884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel anti-VEGF chimeric molecules delivered by AAV vectors for inhibition of retinal neovascularization.
    Pechan P; Rubin H; Lukason M; Ardinger J; DuFresne E; Hauswirth WW; Wadsworth SC; Scaria A
    Gene Ther; 2009 Jan; 16(1):10-6. PubMed ID: 18633446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T2-TrpRS inhibits preretinal neovascularization and enhances physiological vascular regrowth in OIR as assessed by a new method of quantification.
    Banin E; Dorrell MI; Aguilar E; Ritter MR; Aderman CM; Smith AC; Friedlander J; Friedlander M
    Invest Ophthalmol Vis Sci; 2006 May; 47(5):2125-34. PubMed ID: 16639024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adeno-associated virus-mediated antiangiogenic gene therapy with thrombospondin-1 type 1 repeats and endostatin.
    Zhang X; Xu J; Lawler J; Terwilliger E; Parangi S
    Clin Cancer Res; 2007 Jul; 13(13):3968-76. PubMed ID: 17606731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatocyte growth factor/scatter factor promotes retinal angiogenesis through increased urokinase expression.
    Colombo ES; Menicucci G; McGuire PG; Das A
    Invest Ophthalmol Vis Sci; 2007 Apr; 48(4):1793-800. PubMed ID: 17389513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Marked inhibition of retinal neovascularization in rats following soluble-flt-1 gene transfer.
    Rota R; Riccioni T; Zaccarini M; Lamartina S; Gallo AD; Fusco A; Kovesdi I; Balestrazzi E; Abeni DC; Ali RR; Capogrossi MC
    J Gene Med; 2004 Sep; 6(9):992-1002. PubMed ID: 15352072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of metastatic brain tumor growth by intramuscular administration of the endostatin gene.
    Oga M; Takenaga K; Sato Y; Nakajima H; Koshikawa N; Osato K; Sakiyama S
    Int J Oncol; 2003 Jul; 23(1):73-9. PubMed ID: 12792778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endostatin gene therapy on murine lung metastases model utilizing cationic vector-mediated intravenous gene delivery.
    Nakashima Y; Yano M; Kobayashi Y; Moriyama S; Sasaki H; Toyama T; Yamashita H; Fukai I; Iwase H; Yamakawa Y; Fujii Y
    Gene Ther; 2003 Jan; 10(2):123-30. PubMed ID: 12571641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The dipeptide Arg-Gln inhibits retinal neovascularization in the mouse model of oxygen-induced retinopathy.
    Neu J; Afzal A; Pan H; Gallego E; Li N; Li Calzi S; Caballero S; Spoerri PE; Shaw LC; Grant MB
    Invest Ophthalmol Vis Sci; 2006 Jul; 47(7):3151-5. PubMed ID: 16799062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Herbimycin A inhibits angiogenic activity in endothelial cells and reduces neovascularization in a rat model of retinopathy of prematurity.
    McCollum GW; Rajaratnam VS; Bullard LE; Yang R; Penn JS
    Exp Eye Res; 2004 May; 78(5):987-95. PubMed ID: 15051479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.